AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Indiana University School of Medicine at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Indiana University School of Medicine brings 4 presentations to AMP 2026 in Seattle. Its program spans pharmacogenomics and laboratory policy, from a reference material for genotyping AMP's tier 1 and tier 2 pharmacogenomic variants to putting DPYD testing guidelines into practice. It also joins a session on laboratory payment policy and assesses an all-inclusive Duoseq sequencing assay in multiple myeloma.
| Organization | AMP 2026 Attendance |
|---|---|
Indiana University School of Medicine Indianapolis, IN | |
Medical school in Indianapolis, the teaching arm of Indiana University Health, with pathology and laboratory medicine training and molecular diagnostics. | Talk Tue, Nov 10 1:30pm–2:00pm Workshop Wed, Nov 11 12:00pm–12:50pm DPYD - From Guidelines to Implementation Testing DPYD variants before fluoropyrimidine chemotherapy: which variants to include, translating results to dose, and adoption barriers. Talk Fri, Nov 13 10:15am–11:45am Poster Sat, Nov 14 2:00pm–2:15pm |
Find decision makers at Indiana University School of Medicine
Tell us what you sell and we’ll find the people at Indiana University School of Medicine most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction